Key Publications November 10, 2020

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics.

Eur Heart J. 2020;41:2304-2312

Boden WE, Bhatt DL, Toth PP, Ray KK, Chapman MJ, Lüscher TF